nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CYP2C19—Ifosfamide—testicular cancer	0.0574	0.36	CbGbCtD
Escitalopram—CYP3A4—Ifosfamide—testicular cancer	0.0277	0.174	CbGbCtD
Escitalopram—CYP2D6—Vinblastine—testicular cancer	0.0231	0.145	CbGbCtD
Escitalopram—CYP3A4—Vinblastine—testicular cancer	0.0147	0.0923	CbGbCtD
Escitalopram—CYP2D6—Doxorubicin—testicular cancer	0.0142	0.0892	CbGbCtD
Escitalopram—CYP3A4—Etoposide—testicular cancer	0.0133	0.0831	CbGbCtD
Escitalopram—CYP3A4—Doxorubicin—testicular cancer	0.00904	0.0567	CbGbCtD
Escitalopram—Oedema peripheral—Epirubicin—testicular cancer	0.000252	0.0003	CcSEcCtD
Escitalopram—Haematuria—Doxorubicin—testicular cancer	0.000252	0.000299	CcSEcCtD
Escitalopram—Connective tissue disorder—Epirubicin—testicular cancer	0.000252	0.000299	CcSEcCtD
Escitalopram—Urethral disorder—Epirubicin—testicular cancer	0.000251	0.000299	CcSEcCtD
Escitalopram—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00025	0.000297	CcSEcCtD
Escitalopram—Epistaxis—Doxorubicin—testicular cancer	0.000249	0.000296	CcSEcCtD
Escitalopram—Angiopathy—Methotrexate—testicular cancer	0.000248	0.000295	CcSEcCtD
Escitalopram—Sinusitis—Doxorubicin—testicular cancer	0.000248	0.000295	CcSEcCtD
Escitalopram—Immune system disorder—Methotrexate—testicular cancer	0.000247	0.000294	CcSEcCtD
Escitalopram—Visual impairment—Epirubicin—testicular cancer	0.000247	0.000294	CcSEcCtD
Escitalopram—Mediastinal disorder—Methotrexate—testicular cancer	0.000247	0.000293	CcSEcCtD
Escitalopram—Agranulocytosis—Doxorubicin—testicular cancer	0.000246	0.000293	CcSEcCtD
Escitalopram—Chills—Methotrexate—testicular cancer	0.000246	0.000292	CcSEcCtD
Escitalopram—Nausea—Ifosfamide—testicular cancer	0.000244	0.00029	CcSEcCtD
Escitalopram—Diarrhoea—Cisplatin—testicular cancer	0.000242	0.000288	CcSEcCtD
Escitalopram—Erythema multiforme—Epirubicin—testicular cancer	0.000242	0.000288	CcSEcCtD
Escitalopram—Alopecia—Methotrexate—testicular cancer	0.000242	0.000288	CcSEcCtD
Escitalopram—Bradycardia—Doxorubicin—testicular cancer	0.000241	0.000287	CcSEcCtD
Escitalopram—Mental disorder—Methotrexate—testicular cancer	0.00024	0.000285	CcSEcCtD
Escitalopram—Eye disorder—Epirubicin—testicular cancer	0.000239	0.000285	CcSEcCtD
Escitalopram—Hypersensitivity—Etoposide—testicular cancer	0.000239	0.000285	CcSEcCtD
Escitalopram—Tinnitus—Epirubicin—testicular cancer	0.000239	0.000284	CcSEcCtD
Escitalopram—Erythema—Methotrexate—testicular cancer	0.000238	0.000283	CcSEcCtD
Escitalopram—Malnutrition—Methotrexate—testicular cancer	0.000238	0.000283	CcSEcCtD
Escitalopram—Haemoglobin—Doxorubicin—testicular cancer	0.000238	0.000283	CcSEcCtD
Escitalopram—Flushing—Epirubicin—testicular cancer	0.000238	0.000283	CcSEcCtD
Escitalopram—Cardiac disorder—Epirubicin—testicular cancer	0.000238	0.000283	CcSEcCtD
Escitalopram—Rhinitis—Doxorubicin—testicular cancer	0.000238	0.000283	CcSEcCtD
Escitalopram—Haemorrhage—Doxorubicin—testicular cancer	0.000237	0.000282	CcSEcCtD
Escitalopram—Hepatitis—Doxorubicin—testicular cancer	0.000237	0.000282	CcSEcCtD
Escitalopram—Hypoaesthesia—Doxorubicin—testicular cancer	0.000236	0.000281	CcSEcCtD
Escitalopram—Pharyngitis—Doxorubicin—testicular cancer	0.000235	0.00028	CcSEcCtD
Escitalopram—Urinary tract disorder—Doxorubicin—testicular cancer	0.000234	0.000278	CcSEcCtD
Escitalopram—Oedema peripheral—Doxorubicin—testicular cancer	0.000233	0.000278	CcSEcCtD
Escitalopram—Dysgeusia—Methotrexate—testicular cancer	0.000233	0.000278	CcSEcCtD
Escitalopram—Asthenia—Etoposide—testicular cancer	0.000233	0.000277	CcSEcCtD
Escitalopram—Connective tissue disorder—Doxorubicin—testicular cancer	0.000233	0.000277	CcSEcCtD
Escitalopram—Angiopathy—Epirubicin—testicular cancer	0.000232	0.000276	CcSEcCtD
Escitalopram—Urethral disorder—Doxorubicin—testicular cancer	0.000232	0.000276	CcSEcCtD
Escitalopram—Immune system disorder—Epirubicin—testicular cancer	0.000231	0.000275	CcSEcCtD
Escitalopram—Mediastinal disorder—Epirubicin—testicular cancer	0.000231	0.000275	CcSEcCtD
Escitalopram—Back pain—Methotrexate—testicular cancer	0.00023	0.000274	CcSEcCtD
Escitalopram—Chills—Epirubicin—testicular cancer	0.00023	0.000273	CcSEcCtD
Escitalopram—Pruritus—Etoposide—testicular cancer	0.00023	0.000273	CcSEcCtD
Escitalopram—Arrhythmia—Epirubicin—testicular cancer	0.000229	0.000272	CcSEcCtD
Escitalopram—Visual impairment—Doxorubicin—testicular cancer	0.000228	0.000272	CcSEcCtD
Escitalopram—Alopecia—Epirubicin—testicular cancer	0.000226	0.000269	CcSEcCtD
Escitalopram—Vomiting—Cisplatin—testicular cancer	0.000225	0.000268	CcSEcCtD
Escitalopram—Vision blurred—Methotrexate—testicular cancer	0.000225	0.000267	CcSEcCtD
Escitalopram—Mental disorder—Epirubicin—testicular cancer	0.000224	0.000267	CcSEcCtD
Escitalopram—Erythema multiforme—Doxorubicin—testicular cancer	0.000224	0.000267	CcSEcCtD
Escitalopram—Rash—Cisplatin—testicular cancer	0.000223	0.000266	CcSEcCtD
Escitalopram—Dermatitis—Cisplatin—testicular cancer	0.000223	0.000266	CcSEcCtD
Escitalopram—Erythema—Epirubicin—testicular cancer	0.000223	0.000265	CcSEcCtD
Escitalopram—Malnutrition—Epirubicin—testicular cancer	0.000223	0.000265	CcSEcCtD
Escitalopram—Diarrhoea—Etoposide—testicular cancer	0.000222	0.000264	CcSEcCtD
Escitalopram—Eye disorder—Doxorubicin—testicular cancer	0.000221	0.000263	CcSEcCtD
Escitalopram—Ill-defined disorder—Methotrexate—testicular cancer	0.000221	0.000263	CcSEcCtD
Escitalopram—Tinnitus—Doxorubicin—testicular cancer	0.000221	0.000263	CcSEcCtD
Escitalopram—Anaemia—Methotrexate—testicular cancer	0.00022	0.000262	CcSEcCtD
Escitalopram—Flushing—Doxorubicin—testicular cancer	0.00022	0.000262	CcSEcCtD
Escitalopram—Cardiac disorder—Doxorubicin—testicular cancer	0.00022	0.000262	CcSEcCtD
Escitalopram—Flatulence—Epirubicin—testicular cancer	0.00022	0.000261	CcSEcCtD
Escitalopram—Tension—Epirubicin—testicular cancer	0.000219	0.00026	CcSEcCtD
Escitalopram—Dysgeusia—Epirubicin—testicular cancer	0.000218	0.00026	CcSEcCtD
Escitalopram—Nervousness—Epirubicin—testicular cancer	0.000217	0.000258	CcSEcCtD
Escitalopram—Back pain—Epirubicin—testicular cancer	0.000216	0.000257	CcSEcCtD
Escitalopram—Angiopathy—Doxorubicin—testicular cancer	0.000215	0.000256	CcSEcCtD
Escitalopram—Malaise—Methotrexate—testicular cancer	0.000215	0.000256	CcSEcCtD
Escitalopram—Dizziness—Etoposide—testicular cancer	0.000215	0.000255	CcSEcCtD
Escitalopram—Muscle spasms—Epirubicin—testicular cancer	0.000214	0.000255	CcSEcCtD
Escitalopram—Immune system disorder—Doxorubicin—testicular cancer	0.000214	0.000255	CcSEcCtD
Escitalopram—Vertigo—Methotrexate—testicular cancer	0.000214	0.000255	CcSEcCtD
Escitalopram—Mediastinal disorder—Doxorubicin—testicular cancer	0.000214	0.000254	CcSEcCtD
Escitalopram—Leukopenia—Methotrexate—testicular cancer	0.000213	0.000254	CcSEcCtD
Escitalopram—Chills—Doxorubicin—testicular cancer	0.000213	0.000253	CcSEcCtD
Escitalopram—Arrhythmia—Doxorubicin—testicular cancer	0.000212	0.000252	CcSEcCtD
Escitalopram—Nausea—Cisplatin—testicular cancer	0.00021	0.00025	CcSEcCtD
Escitalopram—Vision blurred—Epirubicin—testicular cancer	0.00021	0.00025	CcSEcCtD
Escitalopram—Alopecia—Doxorubicin—testicular cancer	0.000209	0.000249	CcSEcCtD
Escitalopram—Cough—Methotrexate—testicular cancer	0.000208	0.000247	CcSEcCtD
Escitalopram—Mental disorder—Doxorubicin—testicular cancer	0.000208	0.000247	CcSEcCtD
Escitalopram—Ill-defined disorder—Epirubicin—testicular cancer	0.000207	0.000246	CcSEcCtD
Escitalopram—Convulsion—Methotrexate—testicular cancer	0.000206	0.000246	CcSEcCtD
Escitalopram—Vomiting—Etoposide—testicular cancer	0.000206	0.000246	CcSEcCtD
Escitalopram—Malnutrition—Doxorubicin—testicular cancer	0.000206	0.000245	CcSEcCtD
Escitalopram—Erythema—Doxorubicin—testicular cancer	0.000206	0.000245	CcSEcCtD
Escitalopram—Anaemia—Epirubicin—testicular cancer	0.000206	0.000245	CcSEcCtD
Escitalopram—Agitation—Epirubicin—testicular cancer	0.000205	0.000244	CcSEcCtD
Escitalopram—Rash—Etoposide—testicular cancer	0.000205	0.000243	CcSEcCtD
Escitalopram—Dermatitis—Etoposide—testicular cancer	0.000204	0.000243	CcSEcCtD
Escitalopram—Headache—Etoposide—testicular cancer	0.000203	0.000242	CcSEcCtD
Escitalopram—Flatulence—Doxorubicin—testicular cancer	0.000203	0.000242	CcSEcCtD
Escitalopram—Myalgia—Methotrexate—testicular cancer	0.000203	0.000241	CcSEcCtD
Escitalopram—Chest pain—Methotrexate—testicular cancer	0.000203	0.000241	CcSEcCtD
Escitalopram—Arthralgia—Methotrexate—testicular cancer	0.000203	0.000241	CcSEcCtD
Escitalopram—Tension—Doxorubicin—testicular cancer	0.000202	0.000241	CcSEcCtD
Escitalopram—Dysgeusia—Doxorubicin—testicular cancer	0.000202	0.00024	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000201	0.00024	CcSEcCtD
Escitalopram—Malaise—Epirubicin—testicular cancer	0.000201	0.000239	CcSEcCtD
Escitalopram—Discomfort—Methotrexate—testicular cancer	0.0002	0.000238	CcSEcCtD
Escitalopram—Nervousness—Doxorubicin—testicular cancer	0.0002	0.000238	CcSEcCtD
Escitalopram—Vertigo—Epirubicin—testicular cancer	0.0002	0.000238	CcSEcCtD
Escitalopram—Syncope—Epirubicin—testicular cancer	0.0002	0.000238	CcSEcCtD
Escitalopram—Leukopenia—Epirubicin—testicular cancer	0.0002	0.000237	CcSEcCtD
Escitalopram—Back pain—Doxorubicin—testicular cancer	0.0002	0.000237	CcSEcCtD
Escitalopram—Muscle spasms—Doxorubicin—testicular cancer	0.000198	0.000236	CcSEcCtD
Escitalopram—Palpitations—Epirubicin—testicular cancer	0.000197	0.000234	CcSEcCtD
Escitalopram—Confusional state—Methotrexate—testicular cancer	0.000196	0.000233	CcSEcCtD
Escitalopram—Loss of consciousness—Epirubicin—testicular cancer	0.000196	0.000233	CcSEcCtD
Escitalopram—Cough—Epirubicin—testicular cancer	0.000195	0.000231	CcSEcCtD
Escitalopram—Anaphylactic shock—Methotrexate—testicular cancer	0.000194	0.000231	CcSEcCtD
Escitalopram—Vision blurred—Doxorubicin—testicular cancer	0.000194	0.000231	CcSEcCtD
Escitalopram—Convulsion—Epirubicin—testicular cancer	0.000193	0.00023	CcSEcCtD
Escitalopram—Infection—Methotrexate—testicular cancer	0.000193	0.00023	CcSEcCtD
Escitalopram—Nausea—Etoposide—testicular cancer	0.000193	0.000229	CcSEcCtD
Escitalopram—Hypertension—Epirubicin—testicular cancer	0.000192	0.000229	CcSEcCtD
Escitalopram—Ill-defined disorder—Doxorubicin—testicular cancer	0.000191	0.000228	CcSEcCtD
Escitalopram—Nervous system disorder—Methotrexate—testicular cancer	0.000191	0.000227	CcSEcCtD
Escitalopram—Anaemia—Doxorubicin—testicular cancer	0.000191	0.000227	CcSEcCtD
Escitalopram—Thrombocytopenia—Methotrexate—testicular cancer	0.00019	0.000226	CcSEcCtD
Escitalopram—Chest pain—Epirubicin—testicular cancer	0.00019	0.000226	CcSEcCtD
Escitalopram—Myalgia—Epirubicin—testicular cancer	0.00019	0.000226	CcSEcCtD
Escitalopram—Arthralgia—Epirubicin—testicular cancer	0.00019	0.000226	CcSEcCtD
Escitalopram—Agitation—Doxorubicin—testicular cancer	0.00019	0.000226	CcSEcCtD
Escitalopram—Anxiety—Epirubicin—testicular cancer	0.000189	0.000225	CcSEcCtD
Escitalopram—Skin disorder—Methotrexate—testicular cancer	0.000189	0.000225	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000188	0.000224	CcSEcCtD
Escitalopram—Hyperhidrosis—Methotrexate—testicular cancer	0.000188	0.000224	CcSEcCtD
Escitalopram—Discomfort—Epirubicin—testicular cancer	0.000188	0.000223	CcSEcCtD
Escitalopram—Malaise—Doxorubicin—testicular cancer	0.000186	0.000221	CcSEcCtD
Escitalopram—Dry mouth—Epirubicin—testicular cancer	0.000186	0.000221	CcSEcCtD
Escitalopram—Vertigo—Doxorubicin—testicular cancer	0.000185	0.00022	CcSEcCtD
Escitalopram—Anorexia—Methotrexate—testicular cancer	0.000185	0.00022	CcSEcCtD
Escitalopram—Syncope—Doxorubicin—testicular cancer	0.000185	0.00022	CcSEcCtD
Escitalopram—Leukopenia—Doxorubicin—testicular cancer	0.000185	0.00022	CcSEcCtD
Escitalopram—Confusional state—Epirubicin—testicular cancer	0.000183	0.000218	CcSEcCtD
Escitalopram—Palpitations—Doxorubicin—testicular cancer	0.000182	0.000217	CcSEcCtD
Escitalopram—Oedema—Epirubicin—testicular cancer	0.000182	0.000216	CcSEcCtD
Escitalopram—Anaphylactic shock—Epirubicin—testicular cancer	0.000182	0.000216	CcSEcCtD
Escitalopram—Hypotension—Methotrexate—testicular cancer	0.000182	0.000216	CcSEcCtD
Escitalopram—Loss of consciousness—Doxorubicin—testicular cancer	0.000181	0.000216	CcSEcCtD
Escitalopram—Infection—Epirubicin—testicular cancer	0.000181	0.000215	CcSEcCtD
Escitalopram—Cough—Doxorubicin—testicular cancer	0.00018	0.000214	CcSEcCtD
Escitalopram—Shock—Epirubicin—testicular cancer	0.000179	0.000213	CcSEcCtD
Escitalopram—Convulsion—Doxorubicin—testicular cancer	0.000179	0.000213	CcSEcCtD
Escitalopram—Nervous system disorder—Epirubicin—testicular cancer	0.000178	0.000212	CcSEcCtD
Escitalopram—Thrombocytopenia—Epirubicin—testicular cancer	0.000178	0.000212	CcSEcCtD
Escitalopram—Hypertension—Doxorubicin—testicular cancer	0.000178	0.000212	CcSEcCtD
Escitalopram—Tachycardia—Epirubicin—testicular cancer	0.000178	0.000211	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000177	0.000211	CcSEcCtD
Escitalopram—Skin disorder—Epirubicin—testicular cancer	0.000177	0.00021	CcSEcCtD
Escitalopram—Hyperhidrosis—Epirubicin—testicular cancer	0.000176	0.000209	CcSEcCtD
Escitalopram—Insomnia—Methotrexate—testicular cancer	0.000176	0.000209	CcSEcCtD
Escitalopram—Chest pain—Doxorubicin—testicular cancer	0.000176	0.000209	CcSEcCtD
Escitalopram—Arthralgia—Doxorubicin—testicular cancer	0.000176	0.000209	CcSEcCtD
Escitalopram—Myalgia—Doxorubicin—testicular cancer	0.000176	0.000209	CcSEcCtD
Escitalopram—Anxiety—Doxorubicin—testicular cancer	0.000175	0.000208	CcSEcCtD
Escitalopram—Paraesthesia—Methotrexate—testicular cancer	0.000175	0.000208	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000174	0.000207	CcSEcCtD
Escitalopram—Discomfort—Doxorubicin—testicular cancer	0.000174	0.000206	CcSEcCtD
Escitalopram—Anorexia—Epirubicin—testicular cancer	0.000173	0.000206	CcSEcCtD
Escitalopram—Dyspnoea—Methotrexate—testicular cancer	0.000173	0.000206	CcSEcCtD
Escitalopram—Somnolence—Methotrexate—testicular cancer	0.000173	0.000206	CcSEcCtD
Escitalopram—Dry mouth—Doxorubicin—testicular cancer	0.000172	0.000204	CcSEcCtD
Escitalopram—Dyspepsia—Methotrexate—testicular cancer	0.000171	0.000204	CcSEcCtD
Escitalopram—Hypotension—Epirubicin—testicular cancer	0.00017	0.000202	CcSEcCtD
Escitalopram—Confusional state—Doxorubicin—testicular cancer	0.00017	0.000202	CcSEcCtD
Escitalopram—Decreased appetite—Methotrexate—testicular cancer	0.000169	0.000201	CcSEcCtD
Escitalopram—Oedema—Doxorubicin—testicular cancer	0.000168	0.0002	CcSEcCtD
Escitalopram—Anaphylactic shock—Doxorubicin—testicular cancer	0.000168	0.0002	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000168	0.0002	CcSEcCtD
Escitalopram—Fatigue—Methotrexate—testicular cancer	0.000168	0.000199	CcSEcCtD
Escitalopram—Infection—Doxorubicin—testicular cancer	0.000167	0.000199	CcSEcCtD
Escitalopram—Pain—Methotrexate—testicular cancer	0.000166	0.000198	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000166	0.000197	CcSEcCtD
Escitalopram—Shock—Doxorubicin—testicular cancer	0.000166	0.000197	CcSEcCtD
Escitalopram—Nervous system disorder—Doxorubicin—testicular cancer	0.000165	0.000196	CcSEcCtD
Escitalopram—Thrombocytopenia—Doxorubicin—testicular cancer	0.000165	0.000196	CcSEcCtD
Escitalopram—Insomnia—Epirubicin—testicular cancer	0.000165	0.000196	CcSEcCtD
Escitalopram—Tachycardia—Doxorubicin—testicular cancer	0.000164	0.000195	CcSEcCtD
Escitalopram—Skin disorder—Doxorubicin—testicular cancer	0.000164	0.000195	CcSEcCtD
Escitalopram—Paraesthesia—Epirubicin—testicular cancer	0.000163	0.000194	CcSEcCtD
Escitalopram—Hyperhidrosis—Doxorubicin—testicular cancer	0.000163	0.000194	CcSEcCtD
Escitalopram—Dyspnoea—Epirubicin—testicular cancer	0.000162	0.000193	CcSEcCtD
Escitalopram—Somnolence—Epirubicin—testicular cancer	0.000162	0.000192	CcSEcCtD
Escitalopram—Anorexia—Doxorubicin—testicular cancer	0.00016	0.000191	CcSEcCtD
Escitalopram—Feeling abnormal—Methotrexate—testicular cancer	0.00016	0.000191	CcSEcCtD
Escitalopram—Dyspepsia—Epirubicin—testicular cancer	0.00016	0.000191	CcSEcCtD
Escitalopram—Gastrointestinal pain—Methotrexate—testicular cancer	0.000159	0.000189	CcSEcCtD
Escitalopram—Decreased appetite—Epirubicin—testicular cancer	0.000158	0.000188	CcSEcCtD
Escitalopram—Hypotension—Doxorubicin—testicular cancer	0.000157	0.000187	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000157	0.000187	CcSEcCtD
Escitalopram—Fatigue—Epirubicin—testicular cancer	0.000157	0.000187	CcSEcCtD
Escitalopram—Pain—Epirubicin—testicular cancer	0.000156	0.000185	CcSEcCtD
Escitalopram—Constipation—Epirubicin—testicular cancer	0.000156	0.000185	CcSEcCtD
Escitalopram—Urticaria—Methotrexate—testicular cancer	0.000154	0.000184	CcSEcCtD
Escitalopram—Abdominal pain—Methotrexate—testicular cancer	0.000154	0.000183	CcSEcCtD
Escitalopram—Body temperature increased—Methotrexate—testicular cancer	0.000154	0.000183	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000153	0.000182	CcSEcCtD
Escitalopram—Insomnia—Doxorubicin—testicular cancer	0.000152	0.000181	CcSEcCtD
Escitalopram—Paraesthesia—Doxorubicin—testicular cancer	0.000151	0.00018	CcSEcCtD
Escitalopram—Dyspnoea—Doxorubicin—testicular cancer	0.00015	0.000179	CcSEcCtD
Escitalopram—Feeling abnormal—Epirubicin—testicular cancer	0.00015	0.000178	CcSEcCtD
Escitalopram—Somnolence—Doxorubicin—testicular cancer	0.00015	0.000178	CcSEcCtD
Escitalopram—Gastrointestinal pain—Epirubicin—testicular cancer	0.000149	0.000177	CcSEcCtD
Escitalopram—Dyspepsia—Doxorubicin—testicular cancer	0.000148	0.000176	CcSEcCtD
Escitalopram—Decreased appetite—Doxorubicin—testicular cancer	0.000146	0.000174	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000145	0.000173	CcSEcCtD
Escitalopram—Fatigue—Doxorubicin—testicular cancer	0.000145	0.000173	CcSEcCtD
Escitalopram—Urticaria—Epirubicin—testicular cancer	0.000145	0.000172	CcSEcCtD
Escitalopram—Constipation—Doxorubicin—testicular cancer	0.000144	0.000171	CcSEcCtD
Escitalopram—Pain—Doxorubicin—testicular cancer	0.000144	0.000171	CcSEcCtD
Escitalopram—Abdominal pain—Epirubicin—testicular cancer	0.000144	0.000171	CcSEcCtD
Escitalopram—Body temperature increased—Epirubicin—testicular cancer	0.000144	0.000171	CcSEcCtD
Escitalopram—Hypersensitivity—Methotrexate—testicular cancer	0.000143	0.00017	CcSEcCtD
Escitalopram—Asthenia—Methotrexate—testicular cancer	0.000139	0.000166	CcSEcCtD
Escitalopram—Feeling abnormal—Doxorubicin—testicular cancer	0.000139	0.000165	CcSEcCtD
Escitalopram—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000138	0.000164	CcSEcCtD
Escitalopram—Pruritus—Methotrexate—testicular cancer	0.000138	0.000164	CcSEcCtD
Escitalopram—Hypersensitivity—Epirubicin—testicular cancer	0.000134	0.000159	CcSEcCtD
Escitalopram—Urticaria—Doxorubicin—testicular cancer	0.000134	0.000159	CcSEcCtD
Escitalopram—Abdominal pain—Doxorubicin—testicular cancer	0.000133	0.000158	CcSEcCtD
Escitalopram—Body temperature increased—Doxorubicin—testicular cancer	0.000133	0.000158	CcSEcCtD
Escitalopram—Diarrhoea—Methotrexate—testicular cancer	0.000133	0.000158	CcSEcCtD
Escitalopram—Asthenia—Epirubicin—testicular cancer	0.000131	0.000155	CcSEcCtD
Escitalopram—Pruritus—Epirubicin—testicular cancer	0.000129	0.000153	CcSEcCtD
Escitalopram—Dizziness—Methotrexate—testicular cancer	0.000129	0.000153	CcSEcCtD
Escitalopram—Diarrhoea—Epirubicin—testicular cancer	0.000124	0.000148	CcSEcCtD
Escitalopram—Hypersensitivity—Doxorubicin—testicular cancer	0.000124	0.000148	CcSEcCtD
Escitalopram—Vomiting—Methotrexate—testicular cancer	0.000124	0.000147	CcSEcCtD
Escitalopram—Rash—Methotrexate—testicular cancer	0.000123	0.000146	CcSEcCtD
Escitalopram—Dermatitis—Methotrexate—testicular cancer	0.000122	0.000146	CcSEcCtD
Escitalopram—Headache—Methotrexate—testicular cancer	0.000122	0.000145	CcSEcCtD
Escitalopram—Asthenia—Doxorubicin—testicular cancer	0.000121	0.000144	CcSEcCtD
Escitalopram—Dizziness—Epirubicin—testicular cancer	0.00012	0.000143	CcSEcCtD
Escitalopram—Pruritus—Doxorubicin—testicular cancer	0.000119	0.000142	CcSEcCtD
Escitalopram—Vomiting—Epirubicin—testicular cancer	0.000116	0.000138	CcSEcCtD
Escitalopram—Nausea—Methotrexate—testicular cancer	0.000115	0.000137	CcSEcCtD
Escitalopram—Diarrhoea—Doxorubicin—testicular cancer	0.000115	0.000137	CcSEcCtD
Escitalopram—Rash—Epirubicin—testicular cancer	0.000115	0.000136	CcSEcCtD
Escitalopram—Dermatitis—Epirubicin—testicular cancer	0.000115	0.000136	CcSEcCtD
Escitalopram—Headache—Epirubicin—testicular cancer	0.000114	0.000136	CcSEcCtD
Escitalopram—Dizziness—Doxorubicin—testicular cancer	0.000111	0.000132	CcSEcCtD
Escitalopram—Nausea—Epirubicin—testicular cancer	0.000108	0.000129	CcSEcCtD
Escitalopram—Vomiting—Doxorubicin—testicular cancer	0.000107	0.000127	CcSEcCtD
Escitalopram—Rash—Doxorubicin—testicular cancer	0.000106	0.000126	CcSEcCtD
Escitalopram—Dermatitis—Doxorubicin—testicular cancer	0.000106	0.000126	CcSEcCtD
Escitalopram—Headache—Doxorubicin—testicular cancer	0.000105	0.000125	CcSEcCtD
Escitalopram—Nausea—Doxorubicin—testicular cancer	0.0001	0.000119	CcSEcCtD
